Cavalier Investments, LLC Repligen Corp Transaction History

Cavalier Investments, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 06, 2020	SELL	$73.84 - $93.08 $369,200 - $465,400	-5,000 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$54.2 - $85.95 $271,000 - $429,750	5,000 New	5,000 $430,000

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Cavalier Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Cavalier Investments, LLC with notifications on news.